Earlier, Dr Reddy#39;s Laboratories Ltd said the USFDA has issued a Form 483 with 10 observations for its biologics manufacturing facility located in Hyderabad#39;s Bachupally.from Moneycontrol Business News https://ift.tt/d5Pnq4y
Tuesday, November 14, 2023
USFDA flags cleanliness, procedural issues at Dr Reddy#39;s Bachupally unit in Hyderabad
Earlier, Dr Reddy#39;s Laboratories Ltd said the USFDA has issued a Form 483 with 10 observations for its biologics manufacturing facility located in Hyderabad#39;s Bachupally.from Moneycontrol Business News https://ift.tt/d5Pnq4y
Subscribe to:
Post Comments (Atom)
LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally
A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...
-
In a regulatory filing the company said the Odisha Electricity Regulatory Commission (OERC) has awarded the Letter of Intent (LOI) to Tata ...
-
A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...
No comments:
Post a Comment